Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:46 pm Sale | 2023-12-31 | 13G | NEUBASE THERAPEUTICS INC N NBSE | GREENLIGHT CAPITAL INC | 136,350 3.700% | -1 (-0.00%) | Filing History |
| 2023-09-20 5:28 pm Sale | 2023-09-14 | 13D | NEUBASE THERAPEUTICS INC N NBSE | Symetryx Corp | 109,508 3.500% | -363,418 (-76.84%) | Filing History |
| 2023-09-14 06:03 am Purchase | 2023-09-08 | 13D | NEUBASE THERAPEUTICS INC N NBSE | Symetryx Corp | 472,926 9.100% | 44,482 (+10.38%) | Filing History |
| 2023-08-31 11:50 am Purchase | 2023-08-22 | 13D | NEUBASE THERAPEUTICS INC N NBSE | Symetryx Corp | 428,444 13.800% | 428,444 (New Position) | Filing History |
| 2023-01-27 12:49 pm Purchase | 2022-12-29 | 13G | NEUBASE THERAPEUTICS INC NBSE | Kershner Trading Americas LLC | 74,861 4.460% | 7,911 (+11.82%) | Filing History |
| 2022-02-14 3:32 pm Purchase | 2021-12-31 | 13G | NEUBASE THERAPEUTICS INC NBSE | GREENLIGHT CAPITAL INC | 136,351 8.300% | 35,000 (+34.53%) | Filing History |